2-thienylimidazo[2,1-.beta.]benzothiazole-3-acetic acid derivatives,
their preparation and their use
    1.
    发明授权
    2-thienylimidazo[2,1-.beta.]benzothiazole-3-acetic acid derivatives, their preparation and their use 失效
    2-噻吩基咪唑并[2,1-β]苯并噻唑-3-乙酸衍生物,其制备及其应用

    公开(公告)号:US5418248A

    公开(公告)日:1995-05-23

    申请号:US175249

    申请日:1993-12-29

    CPC分类号: C07D513/04

    摘要: Compounds of the formula: ##STR1## in which R.sub.1 represents a hydroxy group, a C.sub.1 -C.sub.4 alkoxy group or an amino group of general formula --NR.sub.4 R.sub.5 in which R.sub.4 and R.sub.5 each represent, independently of each other, a hydrogen atom, a straight or branched C.sub.1 -C.sub.4 alkyl group, an allyl group or a methoxyethyl group, or alternatively --NR.sub.4 R.sub.5 represents a heterocycle containing 3 to 6 carbon atoms,Y represents a thienyl group optionally substituted by an alkyl group, andX represents a hydrogen or halogen atom,are useful as anticonvulsants and auxiolytics.

    摘要翻译: 下式的化合物:其中R 1表示羟基,C 1 -C 4烷氧基或通式-NR 4 R 5的氨基,其中R 4和R 5各自独立地表示氢原子 直链或支链C 1 -C 4烷基,烯丙基或甲氧基乙基,或者-NR4R5表示含有3至6个碳原子的杂环,Y表示任选被烷基取代的噻吩基,X表示氢 或卤素原子,可用作抗惊厥药和辅助溶剂。

    (4-piperidyl)methyl-2,3-dihydro-1H-isoindole and
-2,3,4,5-tetrahydro-1H-benzazepine derivatives, their preparation and
their application in therapy
    2.
    发明授权
    (4-piperidyl)methyl-2,3-dihydro-1H-isoindole and -2,3,4,5-tetrahydro-1H-benzazepine derivatives, their preparation and their application in therapy 失效
    (4-哌啶基)甲基-2,3-二氢-1H-茚并-2,3,4,5-四氢-1H-苯并恶嗪衍生物及其制备及其在治疗中的应用

    公开(公告)号:US5096900A

    公开(公告)日:1992-03-17

    申请号:US503941

    申请日:1990-02-08

    IPC分类号: C07D401/06

    CPC分类号: C07D401/06

    摘要: A benzazepine derivative which is a compound of formula (I): ##STR1## in which: each of m and n denotes the number 1, oreach of m and n denoted the number 2, orm denotes the number 3 and n denoted the number 1; andR denotes hydrogen or a group of formula --Z--R' in which Z denotes a --CO-- or --CH.sub.2 -- group and R' denotes a phenyl group which is unsubstituted or substituted with from one to three substituents selected from halogen atoms, linear or branch (C.sub.1 -C.sub.3) groups and linear or branched (C.sub.1 -C.sub.3) alkoxy groups,or a pharmacologically acceptable acid addition salt.

    摘要翻译: 作为式(I)的化合物的苯并氮杂衍生物:其中:m和n分别表示数1,或m和n分别表示数2,或m表示数3,n表示 1号; 并且R表示氢或式-ZR'的基团,其中Z表示-CO-或-CH2-基团,R'表示未取代的或被1至3个选自以下的取代基取代的苯基:卤原子,直链或 支链(C1-C3)基团和直链或支链(C1-C3)烷氧基,或药理学上可接受的酸加成盐。

    2,3-dihydro-1H-isoindole derivatives and their application in therapy
    3.
    发明授权
    2,3-dihydro-1H-isoindole derivatives and their application in therapy 失效
    2,3-二氢-1H-茚-2-酮衍生物及其在治疗中的应用

    公开(公告)号:US5081128A

    公开(公告)日:1992-01-14

    申请号:US377929

    申请日:1989-07-11

    CPC分类号: C07D401/06

    摘要: A benzazepine derivative which is a compound of formula (I): ##STR1## in which each of m and n denotes the number 1, oreach of m and n denotes the number 2, orm denotes the number 3 and n denotes the number 1; and R denotes hydrogen or a group of formula --Z--R' in which Z denotes a --CO-- or --CH.sub.2 -- group and R' denotes a phenyl group which is unsubtituted or substituted with from one to three substituents selected from halogen atoms, linear or branch (C.sub.1 -C.sub.3) alkyl groups and linear or branched (C.sub.1 -C.sub.3) alkoxy groups, or a pharmacologically acceptable acid addition salt.

    摘要翻译: 作为式(I)的化合物的苯并吖庚因衍生物:其中m和n各自表示数1,或m和n各自表示数2,或m表示数3,n表示数 1; 并且R表示氢或式-ZR'的基团,其中Z表示-CO-或-CH2-基,R'表示未取代或被一至三个选自以下的取代基取代的苯基:卤原子,直链或 支链(C1-C3)烷基和直链或支链(C1-C3)烷氧基,或药理学上可接受的酸加成盐。

    2-aminopyrimidine-4-carboxamide derivatives, their preparaton and their
application in therapy
    4.
    发明授权
    2-aminopyrimidine-4-carboxamide derivatives, their preparaton and their application in therapy 失效
    2-氨基嘧啶-4-羧酰胺衍生物及其制剂及其在治疗中的应用

    公开(公告)号:US5229392A

    公开(公告)日:1993-07-20

    申请号:US872028

    申请日:1992-04-23

    CPC分类号: C07D239/42

    摘要: A compound which is a 2-aminopyrimidine-4-carboxamide derivative represented by general formula (I) ##STR1## in which m represents 2 or 3,n represents 2 or 3,R.sub.1 represents hydrogen or methyl, andX represents a substituent selected from the group consisting of hydrogen, fluorine, chlorine, methoxy, ethoxy, methyl and 1-methylethyl, with the proviso that more than one substituent X may be present in which case each X may be the same or different, or a pharmaceutically acceptable acid addition salt thereof.

    摘要翻译: 作为通式(I)表示的2-氨基嘧啶-4-甲酰胺衍生物的化合物,其中m表示2或3,n表示2或3,R 1表示氢或甲基,X表示 选自氢,氟,氯,甲氧基,乙氧基,甲基和1-甲基乙基的取代基,条件是可以存在多于一个取代基X,在这种情况下,每个X可以相同或不同,或药学上 其可接受的酸加成盐。